A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity

Table 2

Clinicopathologic demographics of patients who underwent a planned excision of an upper extremity synovial sarcoma.

Case

Age (years)

Sex

Location

Size

Depth

Stage

Surgical treatment

Adjuvant treatments

Local recurrence

Mets

Follow-up (months)

Outcome

1

17

Female

Forearm

<5 cm

Deep

IIA

Wide excision

Chemo; NXRT; Brachytherapy

No

No

54

ANED

2

13

Female

Deltoid

>5 cm

Deep

IIB

Wide excision

Chemo; NXRT

No

No

84

ANED

3

18

Male

Thenar webspace

<5 cm

Deep

IIA

Marginal excision

Chemo; NXRT; Brachytherapy

No

No

74

ANED

4

51

Male

Brachial plexus

<5 cm

Deep

IV

Wide excision

Chemo; NXRT

No

Lung

9

DOD

5

60

Female

Antecubital fossa

<5 cm

Deep

IIA

Wide excision; Sural nerve grafting; Radial forearm flap

Chemo; NXRT; IORT

No

No

54

ANED

6

10

Female

Elbow

<5 cm

Deep

IIA

Wide excision; MCL reconstruction radial forearm flap

None

No

No

59

ANED

7

19

Male

Index finger

>5 cm

Superficial

IIB

Ray resection

Chemo; NXRT

Yes

No

15

ADP

8

45

Male

Proximal arm

Unknown

Deep

Unknown

Forequarter amputation

Chemo

Yes

Lung

3

DOD

On presentation; Mets, metastases; NXRT, neoadjuvant radiation; IORT, intraoperative radiation; chemo, chemotherapy; ANED, alive no evidence of disease; ADP, alive with disease progression; DOD, died of disease; MCL, medial collateral ligament.